首页> 外文期刊>Journal of Bioscience and Bioengineering >Wound healing activity and mechanism of action of antimicrobial and lipopolysaccharide-neutralizing peptides from enzymatic hydrolysates of rice bran proteins
【24h】

Wound healing activity and mechanism of action of antimicrobial and lipopolysaccharide-neutralizing peptides from enzymatic hydrolysates of rice bran proteins

机译:米糠蛋白酶水解产物抗菌和脂多糖中和肽的伤口愈合活性及其作用机理

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

In our previous study, we identified multifunctional cationic peptides from enzymatic hydrolysates of rice bran proteins (RBPs) that have antimicrobial and lipopolysaccharide-neutralizing activities. In this study, we investigated the potential of the peptides RBP-LRR, RBP-EKL, and RBP-SSF to promote proliferation, angiogenesis (tube formation), and migration in human umbilical vein endothelial cells (HUVECs). To determine mechanisms of wound healing actions, angiogenic and migration-promoting activities of these peptides were evaluated following pretreatments of HUVECs with specific inhibitors. In these experiments, the cationic peptides RBP-LRR, RBP-EKL, and RBP-SSF induced cell proliferation at low concentrations of 0.1 mu M or 1 mu M. Moreover, the three cationic peptides had angiogenic activities at concentrations more than 1 mu M in tube formation assays, and their effects were similar to those of LL-37. Subsequent scratch migration assays exhibited that RBP-LRR, RBP-EICL, and RBP-SSF promote wound closure at optimum concentrations of 10, 10, and 0.1 mu M, respectively. In further studies, we performed tube formation assays using HUVECs pre-treated with SU5416, which inhibits vascular endothelial growth factor (VEGF) receptors, and suggested the possibility that the three cationic peptides induce angiogenesis by activating VEGF receptors. In corresponding scratch migration assays using HUVECs, pretreatment with the proliferation inhibitor mitomycin C did not alter the effects of RBP-LRR and RBP-EKL, and significant contribution to wound closure were mediated by cell migration regardless of proliferation rates. In contrast, RBP-SSF contributed to wound closure exclusively by promoting cell proliferation. The present data indicate that RBP-LRR, RBP-EKL, and RBP-SSF are candidates for use as wound healing agents. (C) 2019, The Society for Biotechnology, Japan. All rights reserved.
机译:在我们以前的研究中,我们鉴定了来自米糠蛋白(Rbps)的酶水解产物的多功能阳离子肽,其具有抗微生物和脂多糖中和活性。在这项研究中,我们研究了肽RBP-LRR,RBP-EKL和RBP-SSF的潜力,以促进增殖,血管生成(管形成)和人脐静脉内皮细胞(HUVEC)的迁移。为了确定伤口愈合作用的机制,在具有特异性抑制剂的HUVEC的预处理后评估这些肽的血管生成和迁移促进这些肽的活性。在这些实验中,阳离子肽RBP-LRR,RBP-EKL和RBP-SSF诱导的细胞增殖在0.1μm或1μm的低浓度下。此外,三种阳离子肽在超过1μm的浓度下具有血管生成活性在管形成测定中,它们的效果与LL-37的效果类似。随后的划痕迁移测定表明RBP-LRR,RBP-EIC1和RBP-SSF分别以10,10和0.1μm的最佳浓度促进伤口闭合。在进一步的研究中,我们使用用SU5416预处理的HUVEC进行管形成测定,其抑制血管内皮生长因子(VEGF)受体,并表明三种阳离子肽通过激活VEGF受体诱导血管生成的可能性。在使用Huvecs的相应划痕迁移测定中,具有增殖抑制剂丝霉素C的预处理未改变RBP-LRR和RBP-EKL的影响,并且无论增殖率如何,通过细胞迁移介导对伤口闭合的显着贡献。相比之下,RBP-SSF通过促进细胞增殖而有助于伤口闭合。本数据表明RBP-LRR,RBP-EKL和RBP-SSF是用作伤口愈合剂的候选者。 (c)2019年,日本生物技术协会。版权所有。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号